Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStaffline Regulatory News (STAF)

Share Price Information for Staffline (STAF)

Share Price is delayed by 15 minutes
Get Live Data
39.90    1.30 (3.37%)
Bid:
39.90
Ask:
40.00
Spread: 0.10 (0.251%)
Market Cap: £43.66m
STAF Live PriceLast checked at - London Stock Exchange

Intraday Staffline Share Chart

Director/PDMR Shareholding

21 Oct 2009 07:00

RNS Number : 1208B
Staffline Group PLC
21 October 2009
 



21 October 2009

 

STAFFLINE GROUP PLC ("STAFFLINE" OR THE "COMPANY")

Directors Share Option Grant

Staffline announces that it has made an issue of share options to its directors under its existing EMI scheme.

The Company has granted 150,000 share options to each of the Executive Directors, being Andy Hogarth, Marshall Evans, Tim Jackson and Shaun Brittain, subject to certain performance criteria. The award is dependent on the growth in earnings per share from the base of level in the period to  31st December 2008 to that achieved for the year to 31st December 2012. The maximum award would only vest if the earnings per share doubled in this period. The options have been granted at an exercise price of 47.5p. This is part of a total award of 900,000 share options to incentivise the wider management team.

 

For further information, please contact: 

 

 

For further information, please contact:

www.staffline.co.uk

Staffline Group plc

0115 950 0885

Tim Jackson, Finance Director

07720 458626

Altium 

Phil Adams / Paul Lines

0161 831 9133

Smithfield

Reg Hoare / Rebecca Whitehead

020 7360 4900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQBLFLKBBEFBX
Date   Source Headline
29th Mar 20237:00 amRNSDirectorate Change
27th Mar 20232:34 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSHolding(s) in Company
21st Mar 20237:00 amRNS2022 Audited Results
8th Mar 20237:00 amRNSAnalyst & Investor Presentation
1st Mar 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20234:43 pmRNSDirector/PDMR Shareholding
20th Feb 202312:48 pmRNSEBT Share Purchase
17th Feb 20237:01 amRNSDirector/PDMR Shareholding
17th Feb 20237:00 amRNSGrant of Options under 2023 LTIP
13th Feb 202310:50 amRNSReplacement: Director/PDMR Shareholding
10th Feb 202312:25 pmRNSDirector/PDMR Shareholding
10th Feb 20237:00 amRNSDirector/PDMR Shareholding
8th Feb 20237:20 amRNSDirector/PDMR Shareholding
6th Feb 20234:40 pmRNSSecond Price Monitoring Extn
6th Feb 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 20232:01 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirector/PDMR Shareholding
26th Jan 20233:45 pmRNSEBT Share Purchase
26th Jan 202311:59 amRNSDirector/PDMR Shareholding
25th Jan 202311:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSTrading Update & Notice of Results
19th Jan 20237:00 amRNSAppointment of Joint Broker
13th Jan 20237:00 amRNSNotice of Trading Update & Investor Presentation
23rd Dec 20229:44 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSBoard Update
11th Nov 202210:18 amRNSDirector/PDMR Shareholding
9th Nov 20224:26 pmRNSGrant of Options under SAYE Scheme
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
18th Oct 20225:04 pmRNSDirector/PDMR Shareholding
10th Oct 202210:20 amRNSEBT Share Purchase
3rd Oct 20224:53 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:03 amRNSDirector Declaration
27th Sep 20222:06 pmRNSDirector/PDMR Shareholding
18th Aug 20222:26 pmRNSDirector/PDMR Shareholding
15th Aug 202210:04 amRNSDirector/PDMR Shareholding
11th Aug 20227:01 amRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 202211:21 amRNSTotal Voting Rights
9th Aug 202211:20 amRNSHolding(s) in Company
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
3rd Aug 20226:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20226:18 pmRNSEBT Share Purchase
2nd Aug 20227:01 amRNSNew Contract Win
2nd Aug 20227:00 amRNSUnaudited Interim Results
13th Jul 20227:00 amRNSNotice of Results and Investor Presentation
5th Jul 20225:38 pmRNSHolding(s) in Company
5th Jul 20223:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.